United States Non-Specific Cancer Immunotherapy Drug Market Report 2017

January 2017 | 103 pages | ID: U07117B4F67EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Non-Specific Cancer Immunotherapy Drug

Revenue, means the sales value of Non-Specific Cancer Immunotherapy Drug

This report studies sales (consumption) of Non-Specific Cancer Immunotherapy Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• Roche
• Bristol Myers Squibb
• Dendreon (Valeant)
• Novartis
• Seattle Genetics

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Tablet
• Injection

Split by applications, this report focuses on sales, market share and growth rate of Non-Specific Cancer Immunotherapy Drug in each application, can be divided into

• Leukemia Treatment
• Colorectal Cancer Treatment
• Other Cancer Treatment

Contents

United States Non-Specific Cancer Immunotherapy Drug Market Report 2017

1 NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG OVERVIEW

1.1 Product Overview and Scope of Non-Specific Cancer Immunotherapy Drug
1.2 Classification of Non-Specific Cancer Immunotherapy Drug
  1.2.1 Tablet
  1.2.2 Injection
1.3 Application of Non-Specific Cancer Immunotherapy Drug
  1.3.1 Leukemia Treatment
  1.3.2 Colorectal Cancer Treatment
  1.3.3 Other Cancer Treatment
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Non-Specific Cancer Immunotherapy Drug (2011-2021)
  1.4.1 United States Non-Specific Cancer Immunotherapy Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Non-Specific Cancer Immunotherapy Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG COMPETITION BY MANUFACTURERS

2.1 United States Non-Specific Cancer Immunotherapy Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Non-Specific Cancer Immunotherapy Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Non-Specific Cancer Immunotherapy Drug Average Price by Manufactures (2015 and 2016)
2.4 Non-Specific Cancer Immunotherapy Drug Market Competitive Situation and Trends
  2.4.1 Non-Specific Cancer Immunotherapy Drug Market Concentration Rate
  2.4.2 Non-Specific Cancer Immunotherapy Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Non-Specific Cancer Immunotherapy Drug Sales and Market Share by States (2011-2016)
3.2 United States Non-Specific Cancer Immunotherapy Drug Revenue and Market Share by States (2011-2016)
3.3 United States Non-Specific Cancer Immunotherapy Drug Price by States (2011-2016)

4 UNITED STATES NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Non-Specific Cancer Immunotherapy Drug Sales and Market Share by Type (2011-2016)
4.2 United States Non-Specific Cancer Immunotherapy Drug Revenue and Market Share by Type (2011-2016)
4.3 United States Non-Specific Cancer Immunotherapy Drug Price by Type (2011-2016)
4.4 United States Non-Specific Cancer Immunotherapy Drug Sales Growth Rate by Type (2011-2016)

5 UNITED STATES NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Non-Specific Cancer Immunotherapy Drug Sales and Market Share by Application (2011-2016)
5.2 United States Non-Specific Cancer Immunotherapy Drug Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MANUFACTURERS PROFILES/ANALYSIS

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    6.1.2.1 Tablet
    6.1.2.2 Injection
  6.1.3 Amgen Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    6.2.2.1 Tablet
    6.2.2.2 Injection
  6.2.3 Roche Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Bristol Myers Squibb
  6.3.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    6.3.2.1 Tablet
    6.3.2.2 Injection
  6.3.3 Bristol Myers Squibb Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Dendreon (Valeant)
  6.4.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    6.4.2.1 Tablet
    6.4.2.2 Injection
  6.4.3 Dendreon (Valeant) Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Novartis
  6.5.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    6.5.2.1 Tablet
    6.5.2.2 Injection
  6.5.3 Novartis Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Seattle Genetics
  6.6.2 Non-Specific Cancer Immunotherapy Drug Product Type, Application and Specification
    6.6.2.1 Tablet
    6.6.2.2 Injection
  6.6.3 Seattle Genetics Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview

7 NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MANUFACTURING COST ANALYSIS

7.1 Non-Specific Cancer Immunotherapy Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Non-Specific Cancer Immunotherapy Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Non-Specific Cancer Immunotherapy Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Non-Specific Cancer Immunotherapy Drug Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NON-SPECIFIC CANCER IMMUNOTHERAPY DRUG MARKET FORECAST (2016-2021)

11.1 United States Non-Specific Cancer Immunotherapy Drug Sales, Revenue Forecast (2016-2021)
11.2 United States Non-Specific Cancer Immunotherapy Drug Sales Forecast by Type (2016-2021)
11.3 United States Non-Specific Cancer Immunotherapy Drug Sales Forecast by Application (2016-2021)
11.4 Non-Specific Cancer Immunotherapy Drug Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-Specific Cancer Immunotherapy Drug
Table Classification of Non-Specific Cancer Immunotherapy Drug
Figure United States Sales Market Share of Non-Specific Cancer Immunotherapy Drug by Type in 2015
Figure Tablet Picture
Figure Injection Picture
Table Application of Non-Specific Cancer Immunotherapy Drug
Figure United States Sales Market Share of Non-Specific Cancer Immunotherapy Drug by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure United States Non-Specific Cancer Immunotherapy Drug Sales and Growth Rate (2011-2021)
Figure United States Non-Specific Cancer Immunotherapy Drug Revenue and Growth Rate (2011-2021)
Table United States Non-Specific Cancer Immunotherapy Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Non-Specific Cancer Immunotherapy Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-Specific Cancer Immunotherapy Drug Sales Share by Manufacturers
Figure 2016 Non-Specific Cancer Immunotherapy Drug Sales Share by Manufacturers
Table United States Non-Specific Cancer Immunotherapy Drug Revenue by Manufacturers (2015 and 2016)
Table United States Non-Specific Cancer Immunotherapy Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Non-Specific Cancer Immunotherapy Drug Revenue Share by Manufacturers
Table 2016 United States Non-Specific Cancer Immunotherapy Drug Revenue Share by Manufacturers
Table United States Market Non-Specific Cancer Immunotherapy Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Non-Specific Cancer Immunotherapy Drug Average Price of Key Manufacturers in 2015
Figure Non-Specific Cancer Immunotherapy Drug Market Share of Top 3 Manufacturers
Figure Non-Specific Cancer Immunotherapy Drug Market Share of Top 5 Manufacturers
Table United States Non-Specific Cancer Immunotherapy Drug Sales by States (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Sales Share by States (2011-2016)
Figure United States Non-Specific Cancer Immunotherapy Drug Sales Market Share by States in 2015
Table United States Non-Specific Cancer Immunotherapy Drug Revenue and Market Share by States (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Revenue Share by States (2011-2016)
Figure Revenue Market Share of Non-Specific Cancer Immunotherapy Drug by States (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Price by States (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Sales by Type (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Sales Share by Type (2011-2016)
Figure United States Non-Specific Cancer Immunotherapy Drug Sales Market Share by Type in 2015
Table United States Non-Specific Cancer Immunotherapy Drug Revenue and Market Share by Type (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Non-Specific Cancer Immunotherapy Drug by Type (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Price by Type (2011-2016)
Figure United States Non-Specific Cancer Immunotherapy Drug Sales Growth Rate by Type (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Sales by Application (2011-2016)
Table United States Non-Specific Cancer Immunotherapy Drug Sales Market Share by Application (2011-2016)
Figure United States Non-Specific Cancer Immunotherapy Drug Sales Market Share by Application in 2015
Table United States Non-Specific Cancer Immunotherapy Drug Sales Growth Rate by Application (2011-2016)
Figure United States Non-Specific Cancer Immunotherapy Drug Sales Growth Rate by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Non-Specific Cancer Immunotherapy Drug Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Non-Specific Cancer Immunotherapy Drug Sales Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol Myers Squibb Non-Specific Cancer Immunotherapy Drug Sales Market Share (2011-2016)
Table Dendreon (Valeant) Basic Information List
Table Dendreon (Valeant) Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon (Valeant) Non-Specific Cancer Immunotherapy Drug Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Non-Specific Cancer Immunotherapy Drug Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Non-Specific Cancer Immunotherapy Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seattle Genetics Non-Specific Cancer Immunotherapy Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Specific Cancer Immunotherapy Drug
Figure Manufacturing Process Analysis of Non-Specific Cancer Immunotherapy Drug
Figure Non-Specific Cancer Immunotherapy Drug Industrial Chain Analysis
Table Raw Materials Sources of Non-Specific Cancer Immunotherapy Drug Major Manufacturers in 2015
Table Major Buyers of Non-Specific Cancer Immunotherapy Drug
Table Distributors/Traders List
Figure United States Non-Specific Cancer Immunotherapy Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Non-Specific Cancer Immunotherapy Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Non-Specific Cancer Immunotherapy Drug Production Forecast by Type (2016-2021)
Table United States Non-Specific Cancer Immunotherapy Drug Consumption Forecast by Application (2016-2021)
Table United States Non-Specific Cancer Immunotherapy Drug Sales Forecast by States (2016-2021)
Table United States Non-Specific Cancer Immunotherapy Drug Sales Share Forecast by States (2016-2021)